Symbicort News

FDA: Seeking Additional Information On Asthma Drugs - CNNMoney.com

all 21 news articles

Posted: Wed Mar 05 14:52:54 -0500 2008

2nd UPDATE: AstraZeneca: Merck To Keep Interest In Some Products - CNNMoney.com

... including heart drug Toprol XL, asthma treatment Symbicort and blockbuster ulcer treatment Nexium, on which Merck collects royalties. ...

http://money.cnn.com/news/newsfee... | Posted: Thu Feb 28 08:28:20 -0500 2008

Long-acting beta-agonists safe with steroids - Pulse

The MHRA has reviewed data for both currently available LABAs, salemterol and formoterol as well as the combination products Seretide and Symbicort. ...

http://www.pulsetoday.co.uk/story... | Posted: Tue Jan 08 12:12:58 -0500 2008

UPDATE: AstraZeneca Profit Dips After Charges - CNNMoney.com

Turning to individual drugs, sales of asthma medicine Symbicort rose 21% to $ 436 million , sales of breast cancer treatment Arimidex rose 8% to $474 ...

http://money.cnn.com/news/newsfee... | Posted: Thu Jan 31 07:17:26 -0500 2008

AstraZeneca profit slips 12% after charges - MarketWatch

Turning to individual drugs, sales of asthma medicine Symbicort rose 21% to $436 million, sales of breast cancer treatment Arimidex rose 8% to $474 million, ...

http://www.marketwatch.com/news/s... | Posted: Thu Jan 31 08:53:52 -0500 2008

New Drug from Schering-Plough/Novartis Will Become the Clinical ... - SunHerald.com

... will become the clinical gold standard for asthma by 2011, owing to its competitive advantages in delivery over AstraZeneca's Symbicort. ...

http://www.sunherald.com/447/stor... | Posted: Mon Jan 28 09:09:01 -0500 2008

New Drug from Schering-Plough/Novartis Will Become the Clinical ... - SunHerald.com

... will become the clinical gold standard for asthma by 2011, owing to its competitive advantages in delivery over AstraZeneca's Symbicort. ...

Posted: Mon Jan 28 09:09:01 -0500 2008

Dispenser Designer Finds A Way To Make Products Seem Really Cool - CNNMoney.com

Another customer, AstraZeneca (NYSE:AZN) AZN , is using Aptar's product in Symbicort, an asthma spray inhaler introduced last year. ...

http://money.cnn.com/news/newsfee... | Posted: Thu Jan 17 20:13:09 -0500 2008

Efficacy and Familiarity are Key Reasons Physicians Prescribe ... - PR Newswire (press release)

AstraZeneca's Symbicort is Gaining Favor Among Physicians for Use in the Treatment of the Diseases, According to New Reports from Decision Resources WALTHAM ...

http://www.prnewswire.com/cgi-bin... | Posted: Wed Jan 16 08:19:24 -0500 2008